| [1] |
Okunade KS. Human papillomavirus and cervical cance[J]. J Obstet Gynaecol, 2020, 40: 602-608.
|
| [2] |
Wang Z, Yang A, Yang J, et al. Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study[J].Nutr Metab (Lond), 2020, 17: 100-114.
|
| [3] |
Johansson ALV, Fredriksson I, Mellemkjaer L, et al. Cancer survival in women diagnosed with pregnancy-associated cancer: an overview using nationwide registry data in Sweden 1970-2018[J]. Eur J Cancer, 2021, 155: 106-115.
|
| [4] |
Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study[J]. Eur J Cancer, 2020,124: 102-109.
|
| [5] |
Wang T, Jin J, Qian C, et al. Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment[J]. Cancer Cell Int, 2021, 21: 295-308.
|
| [6] |
Ramachandran B. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis[J]. Endocr Relat Cancer, 2017, 24: R99-R108.
|
| [7] |
Bttinger P, Schreiber K, Hyjek E, et al. Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens[J]. Carcinogenesis, 2020, 41: 1605-1615.
|
| [8] |
De Nola R, Menga A, Castegna A, et al. The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: biological pathways and therapeutic implication[J]. Int J Mol Sci, 2019,20:2401-2430.
|
| [9] |
Chen Y, Gu Y, Gu Y, et al. Long noncoding RNA LINC00899/miR-944/ESR1 axis regulates cervical cancer cell proliferation, migration, and invasion[J]. J Interferon Cytokine Res, 2021, 41: 220-233.
|
| [10] |
Gomez-Gomez Y, Organista-Nava J, Ocadiz-Delgado R, et al. The expression of miR-21 and miR-143 is deregu-lated by the HPV16 E7 oncoprotein and 17beta-estradiol[J]. Int J Oncol, 2016, 49: 549-558.
|
| [11] |
Wang C, Zhang T, Wang K, et al. ER-alpha36 promotes the malignant progression of cervical cancer mediated by estrogen via HMGA2[J]. Frontiers in oncology, 2021,11:712849. doi: 10.3389/fonc.2021.712849.
|
| [12] |
Zhang X, Zhang A, Zhang X, et al. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells[J]. Virus research, 2021, 306: 198602. doi: 10.3389/fonc.2021.712849.
|
| [13] |
Fan Q, Huang T, Sun X, et al. miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor alpha and androgen receptor in cervical cancer[J]. Exp Ther Med, 2021, 21: 414-424.
|
| [14] |
Riera Leal A, Ortiz-Lazareno PC, Jave-Suarez LF, et al. 17β-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress[J]. Int J Oncol, 2020, 56: 33-46.
|
| [15] |
Bristol ML, James CD, Wang X, et al. Estrogen attenuates the growth of human papillomavirus-positive epithelial cells[J]. mSphere, 2020, 5:e00049-20. doi: 10.1128/mSphere.00049-20.
|
| [16] |
Kumagai K, Takanashi M, Ohno SI, et al. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7[J]. Oncogene, 2021, 40: 3695-3706.
|
| [17] |
Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis[J]. Cancer Res, 2000, 60: 1267-1275.
|
| [18] |
Remoue F, Jacobs N, Miot V, et al. High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix[J]. Am J Obstet Gynecol, 2003,189: 1660-1665.
|
| [19] |
Spurgeon ME, Uberoi A, McGregor SM, et al. A novel in vivo infection model to study papillomavirus-mediated disease of the female reproductive tract[J]. mBio, 2019, 10:e00180-19. doi: 10.1128/mBio.00180-19.
|
| [20] |
De Nola R, Loizzi V, Cicinelli E, et al. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications[J]. Crit Rev Oncol Hematol, 2021,162: 103343. doi: 10.1016/j.critrevonc.2021.103343.
|
| [21] |
Jayshree RS. The immune microenvironment in human papilloma virus-induced cervical lesions-evidence for estrogen as an immunomodulator[J]. Front Cell Infect Microbiol, 2021, 11: 649815. doi: 10.3389/fcimb.2021.649815.
|
| [22] |
Ramachandran B, Murhekar K, Sundersingh S. SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERalpha expression[J]. Am J Cancer Res, 2021, 11: 3335-3353.
|
| [23] |
Kim L, Park SA, Park H, et al. Bazedoxifene, a GP130 Inhibitor, modulates EMT signaling and exhibits antitumor effects in HPV-positive cervical cancer[J]. Int J Mol Sci, 2021, 22:8693-8706.
|
| [24] |
Chauhan N, Maher DM, Yallapu MM, et al. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth[J]. Sci Rep, 2019, 9:10917-10929.
|
| [25] |
Kwon S, Ahn SH, Jeong WJ, et al. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma[J]. J Transl Med, 2020,18: 240-252.
|
